DEXAMETHASONE, Xtandi - 40 mg soft capsules, PF-06821497, DEXAMETHASONE, PF-06821497, PREDNISOLONE, DOCETAXEL
C2321014
Phase 3 small_molecule active
Quick answer
DEXAMETHASONE, Xtandi - 40 mg soft capsules, PF-06821497, DEXAMETHASONE, PF-06821497, PREDNISOLONE, DOCETAXEL for METASTATIC CASTRATION RESISTANT PROSTATE CANCER is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- METASTATIC CASTRATION RESISTANT PROSTATE CANCER
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active